Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07617714

Adapted Physical Activity (APA) Following Hospitalization in Frail Older Adults

To evaluate the effectiveness of an Adapted Physical Activity (APA) program in improving functional capacity and reducing frailty in older adults following hospital discharge.

The aim is to determine whether a structured program of personalized exercises improves mobility, strength, and quality of life compared to standard care.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The study is open to individuals aged 65 and older.
  • Current diagnosis or recent history of cancer.
  • Patients currently undergoing treatment (chemotherapy, immunotherapy, targeted therapy) or in follow-up after recent treatment (≤12 months since completion).
  • Functional capacity compatible with participation in an adapted physical activity program, as determined by clinical assessment.
  • Recent hospitalization: Patients must have been discharged following a hospital stay.
  • Frailty: Presence of a significant level of frailty at hospital discharge.

Exclusion criteria

  • Short Physical Performance Battery> 10: Patients considered "robust" are excluded to maximize the relevance of the intervention.
  • Acute unstable medical condition or contraindication to exercise: Any unstabilized acute condition that makes physical activity dangerous (e.g., acute cardiac complication, ongoing severe infection). Recent major medical events (myocardial infarction, major surgery, bone fracture, or major amputation in the past few weeks) will also be excluded.
  • Severe chronic conditions incompatible with exercise: Severe progressive diseases that prevent safe exercise, such as severe neuromuscular diseases or advanced organ failure (e.g., end-stage renal failure).
  • Short-term life-threatening prognosis: Patients in the terminal phase or with a very limited life expectancy (less than 6 months).
  • Total functional dependence or severe motor impairment: Patients who are completely dependent for basic activities (very low Barthel Index, e.g., <20/100) or who are unable to move even minimally (e.g., unable to walk a few steps or stand, even with assistance).
  • Severe cognitive impairment: Severe cognitive impairment (e.g., advanced dementia without the ability to follow simple instructions) that prevents active participation in the program.
  • Severe sensory or communication disorders: Significant sensory impairments-such as profound uncompensated blindness or deafness-or any communication barrier (severe aphasia, language barrier) that prevents participation in the program, unless a caregiver (family member or professional) can be present to ensure safety during the exercises.
  • Institutionalization of the patient: Individuals who do not live in their usual residence are excluded. The study focuses on older adults returning home, as the institutional setting involves different care.
  • Lack of valid informed consent: Any patient who refuses to participate or who cannot provide valid consent (due to lack of legal capacity or understanding) will be excluded.
  • Participation in another concurrent program or trial: Simultaneous participation in another physical exercise program or trial.

Treatment and study plan

Adapted Physical Activity program

Other

a 14-week Adapted Physical Activity (APA) program following hospital discharge

Routine care

Other

Participants in the control group will receive standard post-discharge care, along with general recommendations for physical activity and healthy lifestyle habits

Primary outcomes

  1. Improvement in overall physical function assessed by changes in the Short Physical Performance Battery (SPPB) score."

    Time frame: 4 months

Study contacts

Contact information is provided by the study sponsor or research team.

Elena Galve, Doctor

CONTACT

[email protected]

944006000

Sponsors and collaborators

Lead sponsor

Biobizkaia Health Research Institute

Other Gov

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 1, 2026
Registry last updated
Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.